Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Biol Psychiatry. 2022 Dec 24;93(7):594–605. doi: 10.1016/j.biopsych.2022.12.015

Figure 2. Genetically engineered brain organoids derived from healthy donors for functional studies of risk gene variants.

Figure 2.

Engineered brain organoids can be used for highly efficient functional screening and in-depth phenotypic convergence studies of protein-coding risk genes and non-coding SNP variants.